Table 3 Comparison of patient outcomes between the concomitant CABG and non-CABG groups among hemiarch replacement patients
Variable | Non-Concomitant CABG (N = 377) | Concomitant CABG (N = 42) | Overall (N = 419) | p-value |
|---|---|---|---|---|
Intraoperative Blood Products | ||||
RBC Received | 154 (40.8%) | 25 (59.5%) | 179 (42.7%) | 0.031 |
RBC Transfusion Unit | 0 [0–3] | 1 [0–3] | 0 [0–3] | 0.087 |
FFP Received | 220 (58.4%) | 32 (76.2%) | 252 (60.1%) | 0.038 |
FFP Transfusion Unit | 2 [0–4] | 4 [2–4] | 2 [0–4] | 0.010 |
PLT Received | 227 (60.2%) | 34 (81%) | 261 (62.3%) | 0.014 |
PLT Transfusion Unit | 1 [0–2] | 2 [1–2.8] | 1 [0–2] | < 0.001 |
Postoperative Complications | ||||
MACE | 11 (2.9%) | 9 (21.4%) | 20 (4.8%) | < 0.001 |
Myocardial Infarction | 1 (0.3%) | 1 (2.4%) | 2 (0.5%) | 0.191 |
Stroke | 8 (2.1%) | 4 (9.5%) | 12 (2.9%) | 0.024 |
Mortality (within 30 days) | 2 (0.5%) | 4 (9.5%) | 6 (1.4%) | 0.001 |
Acute Kidney Injury | 2 (0.5%) | 7 (16.7%) | 9 (2.1%) | < 0.001 |
New Hemodialysis | 2 (0.5%) | 2 (4.8%) | 4 (1%) | 0.052 |
Need For MCS | 7 (1.9%) | 5 (11.9%) | 12 (2.9%) | 0.004 |
Deep Vein Thrombosis | 4 (1.1%) | 1 (2.4%) | 5 (1.2%) | 0.412 |
Delirium | 25 (6.6%) | 6 (14.3%) | 31 (7.4%) | 0.110 |
Seizure | 7 (1.9%) | 1 (2.4%) | 8 (1.9%) | 0.574 |
Prolonged Ventilation | 13 (3.4%) | 4 (9.5%) | 17 (4.1%) | 0.079 |
Infection | 14 (3.7%) | 5 (11.9%) | 19 (4.5%) | 0.032 |
Arrhythmia | 82 (21.8%) | 17 (40.5%) | 99 (23.6%) | 0.012 |
Length of Stay | 7 [6–9] | 8 [7–10] | 7 [6–9] | 0.002 |
Late Mortality (> 30 days) | 22 (5.9%) | 3 (7.9%) | 25 (6%) | 0.492 |
Stroke-related late death | 2 (7.4%) | 0 (0.0%) | 2 (0.5%) | 1.000 |